Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
06/2005
06/02/2005US20050119305 N-hydroxy-6-[(4-phenylbenzoyl)amino]hexanamide; hydroxamic acid derivative and equivalent thereof; antiinflammatory, anticarcinogenic, antiarthritic, antidiabetic agents; sepsis, leukemia, osteoporosis, skin disorders, cachexia, autoimmune diseases, hepatitis, endometriosis; hypergammaglobulinemia
06/02/2005US20050119282 Pyrazolopyrimidines and related analogs as HSP90-inhibitors
06/02/2005US20050119233 Acyl phosphonate inhibitors of beta-lactamases
06/02/2005US20050119227 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/02/2005US20050118669 Reporter genes; fluorescence activated cell sorting
06/02/2005US20050118248 fatty acid chain are derived from natural vegetable oils such as vernonia oil, lesquerella oil and castor oil, in which the several reactive groups such as epoxy, hydroxy and double bonds can be modified to polar and ionic groups
06/02/2005US20050118131 N-(hydroxy-sulfato or phosphato-alkanoyl) fatty amines; excellent permeability barrier, improved water solubility; skin has improved moisture retention
06/02/2005DE10350999A1 Katalysator, umfassend wenigstens einen Nickel(O)Komplex stabilisiert durch einen sterisch anspruchsvollen Chelatphosphinitphosphitliganden, sowie ein Verfahren zur Herstellung von Nitrilen A catalyst comprising at least one nickel (O) complex stabilized by a bulky Chelatphosphinitphosphitliganden, and a process for the preparation of nitriles
06/02/2005DE10350676A1 Verfahren zur Herstellung eines Alkenylphosphonsäure-Derivats A process for the preparation of a derivative alkenylphosphonic
06/02/2005DE10350674A1 Verfahren zur Herstellung eines Alkenylphosphonsäure-Derivats A process for the preparation of a derivative alkenylphosphonic
06/02/2005CA2546643A1 Isoflavonoid prodrugs, compositions thereof and therapeutic methods involving same
06/01/2005EP1535936A1 Improved method of preparing a hydrocarbylated metal-organic compound
06/01/2005EP1535926A1 Carbacyclic phosphatidic acid derivative
06/01/2005EP1534721A1 Process for controlling the hydrate mix of a compound
06/01/2005EP1534720A1 Mitochondrially targeted antioxidants
06/01/2005EP1534718A1 Chemical synthesis of reagents for peptide coupling
06/01/2005EP1534658A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
06/01/2005EP1534657A1 Process for preparing aldehyde compounds
06/01/2005EP1534427A1 An adamantyl catalytic system
06/01/2005EP1534290A2 Novel inhibitors of kinases
06/01/2005EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors
06/01/2005EP1399452B1 Biomembrane mimetic surface coatings
06/01/2005EP1219626B1 Compounds for fluorescence labeling
06/01/2005EP1124838B1 Nucleic acid labeling compounds
06/01/2005EP1095015B1 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators
06/01/2005EP0954573B1 Preparation of ionically cross-linked polyphosphazene microspheres by coacervation
06/01/2005CN1622949A Improved method for the production of biphosphites
06/01/2005CN1622948A Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
06/01/2005CN1622925A Method for the separation of acids from chemical reaction mixtures by means of ionic fluids
06/01/2005CN1621408A Preparation method of amorphous adefovir dipivoxil
06/01/2005CN1621407A Diphosphonic acid derivative, radioactive 99mTc labeled diphosphonic acid derivative and uses thereof
06/01/2005CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy
05/2005
05/31/2005US6900352 Ligand for coordination polymerization catalysts
05/31/2005US6900347 Reduced production of unwanted byproducts; purity, efficiency
05/31/2005US6900338 Scavenger compounds
05/31/2005US6900321 Substituted pyridyl amine complexes, and catalysts
05/31/2005US6900280 Addition polymer using free radical catalyst; photopolymerization
05/31/2005US6900278 Ligands, complex compounds and their use for polymerising olefins
05/31/2005US6900257 Antistatic agents and polymer compositions derived therefrom
05/31/2005US6900256 Flame retardancy even when using a small amount; to provide thermoplastic resin with improvement in balance of properties such as flame retardancy, thermal stability, workability, impact strength, heat resistance, appearance
05/31/2005US6900251 Waterproof cements, adhesives
05/26/2005WO2005047465A2 Method and antisense compound for potentiating anti-cancer agents
05/26/2005WO2005047299A2 Chiral di- and triphosphites
05/26/2005WO2005047282A1 Antiresorptive mutual salt of raloxifene and bisphosphonic acid
05/26/2005WO2005047236A1 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
05/26/2005WO2005047230A1 Bis-cationic compounds and use thereof
05/26/2005WO2005021484A3 Method for producing ionic liquids, ionic solids or mixtures thereof
05/26/2005WO2005002626A3 Therapeutic phosphonate compounds
05/26/2005WO2004104015A8 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases
05/26/2005WO2004089920A8 Amine-substituted diphenyldiphosphines and the use thereof in metal complexes for asymmetric syntheses
05/26/2005US20050113602 Preparation of an alkenylphosphonic acid derivative
05/26/2005US20050113593 Reacting phosphonic acid derivative with an alkyne in the presence of a catalyst complex comprising nickel and phosphines having two and one trivalent phosphorus atoms where the alkyne is added only after phosphonic acid derivative has been brought into contact with catalyst complex for one minute
05/26/2005US20050113590 High metathesis activity ruthenium and osmium metal carbene complexes
05/26/2005US20050113416 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
05/26/2005US20050113372 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin
05/26/2005US20050113346 making sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation
05/26/2005US20050113345 Amidoalkyl phosphates, e.g., 3-(lauramido-3-hexylpropoxy)-2-lauramidopropyl 2-([3-p-hydroxyphenyl)-2-carboxypropionylamino]ethyl phosphate; used for treating inflammatory conditions such as inflammatory bowel disease and for identifying agents that inhibit activation of Toll-like receptor 2
05/26/2005US20050113343 Solid-state form of alendronate sodium and preparation thereof
05/26/2005US20050113341 Stent with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
05/26/2005US20050113340 9-(Substituted aryl, heteroaryl, alicyclyl, or heterocyclyl)methyl-2-amino-6-halopurines, e.g., 6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine; used in the treatment and prevention of various Heat Shock Protein 90 mediated disorders, e.g., proliferative disorders
05/26/2005US20050113339 inflammatory diseases, infections, autoimmune disorders, stroke, ischemia, cardiac disorder, neurological disorders, fibrogenetic disorders, proliferative disorders, tumors, leukemias, neoplasms, cancers, carcinomas, metabolic diseases, and malignant disease
05/26/2005US20050113338 Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
05/26/2005US20050113328 Method and antisense compound for potentiating anti-cancer agents
05/26/2005US20050112673 Fluorescence quenching azo dyes, their methods of preparation and use
05/26/2005CA2546218A1 Chiral di- and triphosphites
05/26/2005CA2544923A1 Method and antisense compound for potentiating anti-cancer agents
05/25/2005EP1532157A2 Novel phosphonic acid based prodrugs of pmea and its analogues
05/25/2005EP1532108A2 Structural carotenoid analogs for the inhibition and amelioration of disease
05/25/2005EP1532100A1 Method for the enantioselective hydrogenation of amino alcohols
05/25/2005EP1360004B1 Catalysts
05/25/2005EP1047701B1 Mitochondrially targeted antioxidants
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005DE10350722A1 Metallkomplexe Metal complexes
05/25/2005DE10348022A1 Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen New dipeptidyl peptidase IV inhibitors for the functional influence of different cells and for the treatment of immunological, inflammatory, neuronal and other diseases
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620427A Pseudo-nervonic amide and cosmetics composition containing the same
05/25/2005CN1620426A Method for producing quaternary salt phenolate solutions and for regenerating and recycling quaternary salt phenolate solutions from reaction mixtures
05/24/2005US6897341 Bis(aminostyryl)naphthalene compound, synthesis intermediate thereof, and process for production thereof
05/24/2005US6897323 Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
05/24/2005US6897314 Process for preparing imidazoquinolinamines
05/24/2005US6897306 3-heterocyclylpropanohydroxamic acids
05/24/2005US6897276 Coordination polymerization catalyst for alpha-olefins
05/24/2005US6897275 Catalysts for olefin polymerization
05/24/2005US6896871 For therapy of soft tissues surrounding bone and bone-related diseases, such as bone cancer and osteoporosis
05/24/2005CA2227491C In situ preparation of nucleoside phosphoramidites and oligonucleotide synthesis
05/24/2005CA2166381C An improved method of preparing glyoxylic acid/aminomethylphosphonic acid mixtures using a microbial double-transformant
05/24/2005CA2132847C Mixed ligand metal complexes of nitric oxide-nucleophile adducts useful as cardiovascular agents
05/19/2005WO2005044831A2 A process for preparation of bisphosphonic acid compounds
05/19/2005WO2005044830A1 Phosphinic acids derivatives, beta-secretase inhibitors for the treatment of alzheimer’s disease
05/19/2005WO2005044757A1 Diastereoselective method of preparing olefins by means of the horner-wadsworth-emmons reaction using a particular phosphonate which improves diastereoselectivity at all temperatures including at ambient temperature
05/19/2005WO2005044444A1 Oligomerization catalyst for olefin
05/19/2005WO2005044308A1 Phosphonate analogs of antimetabolites
05/19/2005WO2005012220A9 Cycloalkylidene compounds as modulators of estrogen receptor
05/19/2005WO2004029064A8 (+)-trans-isomers of (1-phosphonomethoxy-2-alkylcyclopropyl) methyl nucleoside derivatives, process for the preparation of stereoisomers thereof, and use of antiviral agents thereof
05/19/2005WO2003097792A3 Polypeptide immobilization
05/19/2005US20050107625 Carbonylation catalyst system containing a source of Pt group metal cations and a bidentate diphosphine with two symmetrical phosphabicycloalkyl rings connected by a bridging group, particularly alpha-omega-bis(9-phosphabicyclo[3.3.1]non-9-yl)alkanes
05/19/2005US20050107617 Mobility-modifying cyanine dyes
05/19/2005US20050107608 Ligands for use in catalytic processes
05/19/2005US20050107599 For (back) extracting rare earth metal ions from aqueous solutions
05/19/2005US20050107579 i.e. tris(4-thiophenyl)phosphine sulphide; improved ultraviolet radiation cut
1 ... 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 ... 554